104 related articles for article (PubMed ID: 3323994)
1. [Significance of CA-125 antigen in the monitoring of therapy and clinical course of ovarian cancer].
Pulay T; Csömör S
Orv Hetil; 1987 Dec; 128(50):2615-9. PubMed ID: 3323994
[No Abstract] [Full Text] [Related]
2. [Serologic monitoring of patients with endometrial carcinoma using ovarian carcinoma antigen (CA 125)].
Göcze P; Varhson H
Orv Hetil; 1993 Mar; 134(13):685-8. PubMed ID: 8460017
[TBL] [Abstract][Full Text] [Related]
3. [Predictive value of a tumor marker combination for the monitoring of ovarian cancer].
Lahousen M
Wien Klin Wochenschr; 1986 May; 98(10):319-25. PubMed ID: 3460273
[TBL] [Abstract][Full Text] [Related]
4. [Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].
Göcze P; Vahrson H
Orv Hetil; 1993 Apr; 134(17):915-8. PubMed ID: 8479736
[TBL] [Abstract][Full Text] [Related]
5. CA 125 for the monitoring of ovarian carcinoma during primary therapy.
Lavin PT; Knapp RC; Malkasian G; Whitney CW; Berek JC; Bast RC
Obstet Gynecol; 1987 Feb; 69(2):223-7. PubMed ID: 2433652
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis of the recurrence of epithelial ovarian cancer with the tumor marker CA 125].
Sevelda P; Wagner G
Wien Klin Wochenschr; 1987 Nov; 99(21):768-70. PubMed ID: 3480655
[TBL] [Abstract][Full Text] [Related]
8. [CA 125 in the diagnosis and evaluation of the efficacy of the treatment of cancer of the ovaries].
Sagan DL; Chebotareva ED; Evtushenko GV
Med Radiol (Mosk); 1989 Jun; 34(6):39-42. PubMed ID: 2739519
[TBL] [Abstract][Full Text] [Related]
9. Is serum CA 125 at the time of relapse a prognostic indicator for further survival prognosis in patients with ovarian cancer?
Makar AP; Kristensen GB; Børmer OP; Tropé CG
Gynecol Oncol; 1993 Apr; 49(1):3-7. PubMed ID: 8482556
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the serum levels of a carbohydrate antigen 19-9 (CA 19-9) in patients with ovarian cancer].
Miyoshi T; Nishimura H; Ookura N; Morisaki H; Kobayashi H; Tasaki T; Ushijima H; Yakushiji M
Igaku Kenkyu; 1984 Dec; 54(8):796-800. PubMed ID: 6599577
[No Abstract] [Full Text] [Related]
11. Cancer cell-expressed immunoglobulins: CA215 as a pan cancer marker and its diagnostic applications.
Lee G
Cancer Biomark; 2009; 5(3):137-42. PubMed ID: 19407368
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of 3 markers in ovarian cancer: CA 125, CA 19,9 and CEA].
Vigné E; Krebs B; Khater R; Mira R; Boublil JL; Jourlait A; Frenay M; Namer M
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(5):609-13. PubMed ID: 3463621
[TBL] [Abstract][Full Text] [Related]
13. [Cancer of the ovary. Comparative value of serum CA-125, immunochemistry and biological tests of inflammation].
Gosselin P; Cazin JL; Dehaut JP; Delobelle A; Granier AM; Sulman C; Demaille MC
Rev Fr Gynecol Obstet; 1987 Jan; 82(1):1-5. PubMed ID: 3554460
[TBL] [Abstract][Full Text] [Related]
14. [Significance of CA 125 antigen levels in patients with ovarian cancer].
Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors].
Ferrero JM; Largillier R; Ramaioli A; Heudier P; Teissier E; Namer M
Bull Cancer; 1997 Jul; 84(7):722-8. PubMed ID: 9339198
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results on the use of Ca 15-3 in malignant ovarian pathology.
Ferdeghini M; Gadducci A; Romagnoli S; Bartolini T; Facchini V; Scatena P; Bianchi R; Fioretti P
J Nucl Med Allied Sci; 1987; 31(4):299-302. PubMed ID: 3481812
[No Abstract] [Full Text] [Related]
17. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
18. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
Hasholzner U; Baumgartner L; Stieber P; Meier W; Hofmann K; Fateh-Moghadam A
Anticancer Res; 1994; 14(6B):2743-6. PubMed ID: 7532929
[TBL] [Abstract][Full Text] [Related]
19. [Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer].
Gadducci A; Ferdeghini M; Bartolini T; Facchini V; Bianchi R; Fioretti P
Ann Ostet Ginecol Med Perinat; 1986; 107(4):193-9. PubMed ID: 3467641
[No Abstract] [Full Text] [Related]
20. [Interaction of natural autoantibodies to human ovarian tumor associated antigen with ovarian cancer cells from CaO-1 mice].
Amandzholov BS; Lebedin IuS; Chukanov SV; Toptygin AIu; Sidtikova SM; Moroz LL; Manziuk LV; Donenko FV
Biull Eksp Biol Med; 1999 Feb; 127(2):227-9. PubMed ID: 10095964
[No Abstract] [Full Text] [Related]
[Next] [New Search]
